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Abstract
Recently genome-wide association studies (GWAS) have identified numerous susceptibility variants for complex diseases. In
this study we proposed several approaches to estimate the total number of variants underlying these diseases. We assume
that the variance explained by genetic markers (Vg) follow an exponential distribution, which is justified by previous studies
on theories of adaptation. Our aim is to fit the observed distribution of Vg from GWAS to its theoretical distribution. The
number of variants is obtained by the heritability divided by the estimated mean of the exponential distribution. In practice,
due to limited sample sizes, there is insufficient power to detect variants with small effects. Therefore the power was taken
into account in fitting. Besides considering the most significant variants, we also tried to relax the significance threshold,
allowing more markers to be fitted. The effects of false positive variants were removed by considering the local false
discovery rates. In addition, we developed an alternative approach by directly fitting the z-statistics from GWAS to its
theoretical distribution. In all cases, the ‘‘winner’s curse’’ effect was corrected analytically. Confidence intervals were also
derived. Simulations were performed to compare and verify the performance of different estimators (which incorporates
various means of winner’s curse correction) and the coverage of the proposed analytic confidence intervals. Our
methodology only requires summary statistics and is able to handle both binary and continuous traits. Finally we applied
the methods to a few real disease examples (lipid traits, type 2 diabetes and Crohn’s disease) and estimated that hundreds
to nearly a thousand variants underlie these traits.
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Introduction
The number of genome-wide association studies (GWAS) has
grown rapidly in the past few years [1]. GWAS have identified a
number of robust associations for complex diseases like breast
cancer, prostate cancer, type 1 and 2 diabetes etc. As more
variants are discovered, it is natural to ask: what is the total number
of susceptibility variants that underlie these complex diseases? Or
equivalently, how many more variants need to be found in order
to explain the entire heritability?
It turns out that the results from GWAS could provide
important clues to the above questions. We developed a
methodology to tackle the problem by fitting distributions to the
GWAS results. We assumed that the effect sizes of all susceptibility
variants in the genome, as measured by the variance explained
(Vg), follow an exponential distribution. For binary traits, the
variance explained is computed based on the liability threshold
model. The model proposes a latent continuous liability, which is
assumed to follow a normal distribution with mean 0 and variance
1. The variance in liability explained can be directly interpreted as
the locus-specific heritability. The method is described in details in
another paper [2].
Our aim is to fit the observed distribution of Vg from GWAS to its
theoretical distribution. In practice, the sample size of a study is limited
and there is inadequate power to detect variants with small effect sizes.
As a result, variants with larger effects are over-represented and the Vg
of the discovered variants would not follow a standard exponential
curve. To correct for this bias, we also considered the statistical power
corresponding to every given Vg. In addition, we developed an
alternative estimator of the number of variants by directly fitting a
suitable distribution to the observed z-statistics.
The assumption of an exponential distribution of effect sizes is
theoretically justified. Orr [3] studied Fisher’s model of adaptation
and considered random adaptive walks to the optimum. He
showed that the sizes of the factors fixed during adaptation assume
an exponential distribution. The exponential model was also
supported by a paper by Bost et al. [4], in which fluxes through
metabolic pathways were studied.
The problem of the total number of variants in the genome is
rarely addressed. Recently a study by Pawitan et al. [5] asked a
similar question. However, their methods and focus is largely
different from our current study. In their study, they have
constructed several hypothetical scenarios of allele frequencies and
odds ratios (ORs), and estimated the number of variants required to
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make up a total 40% of heritability. Assuming a pattern of allele
frequencies and ORs ‘‘similar’’ to what has been observed for
confirmed variants, they also estimated the number of susceptibility
variants for type 2 diabetes. However the details of calculations were
not shown. They also employed variance in liability explained as an
effect size measure, which is similar to our study (but we assume a
normal distribution of the underlying liability rather than a logistic
distribution). In contrast to Pawitan et al., we did not construct
specific combinations of allele frequencies and ORs, instead we fit
appropriate distributions to actual GWAS data to estimate the
number of variants. The array of methodologies presented in this
paper has not been previously described.
At the time of submission, we also noticed an interesting paper by
Park et al. [6] which have addressed a similar problem. However,
the problem addressed in this study is not exactly the same as in Park
et al. We are considering the entire range of effect sizes while in Park
et al the range of effect sizes is limited to those observed for known
susceptibility variants. In other words, Park et al. aimed at
estimating the total number of variants within the range of effect sizes
that have been observed in GWAS conducted to date. On the other hand, we
aimed at providing a framework to evaluate the total number of variants
underlying a disease, regardless of the effect sizes of variants. The number of
variants estimated from Park et al. will therefore be smaller than the
number from our approach. For example, for Crohn’s disease, Park
et al. estimated the number of loci to be ,150 within the range of
effect sizes of known loci while our estimate is around a thousand (as
detailed in later sections). Park et al [6] also addressed issues of
power calculations for future GWAS and estimate predictive power
of common variants using AUC (area under the curve of the
receiver operating characteristic curve). Our study is more focused
on exploring various approaches to estimation of the number of
variants and tackling the complications involved, such as different
ways to correct for winner’s curse, relaxing the significance
threshold with correction for false positives and deriving the
confidence intervals analytically. We have also perfozrmed
extensive simulations to compare and verify the performance of
totally fourteen different proposed estimators.
Methods
Exponential distribution of Vg for all susceptibility
variants in the genome
We assume that the Vg of all susceptibility variants in the genome
follow an exponential distribution. The probability density function
(pdf) of an exponential distribution can be expressed as
f (Vg; l)~le{lVg
where the rate l is the only parameter that characterize the
distribution. The mean is simply given by 1/l. Therefore the
number of susceptibility variants can be derived given l:
No: of susceptibility variants~h2=E(Vg)~h2=(1=l)~h2l
where h2 is the total heritability.
Probability density function for Vg in GWAS and fitting
by maximum likelihood
In practice one cannot observe all the susceptibility variants.
Suppose a GWAS was performed and some variants were found to
be associated with p-values below a certain threshold a. The
probability density of the Vg of these observed significant variants
is directly proportional to the standard exponential density
multiplied by the power:
f (Vg)!le{lVg|pwr(Vg)
where pwr is a function that returns the corresponding power for a
given Vg, assuming allele frequency, prevalence, type I error (p-value
cutoff) and sample size are all fixed. Examples of the power-adjusted
pdf for different sample sizes are shown in Figure 1. The power was
evaluated based on a simple approach described in detail in So and
Sham [7]. Briefly, we computed z= ln(OR)/SE(ln OR) under H1
and estimated the corresponding power. Here we take advantage of
the fact that the power corresponding to a given Vg is grossly similar
regardless of the risk allele frequency (see Table S1 for some
examples). The allele frequency was therefore not taken into account
for power calculation but was set at a fixed value (0.5). The problem
will however be significantly complicated if we do consider the
modest difference in power for different allele frequencies, as the
above simple formulation of Vg distribution can no longer be
applied. For a continuous outcome, the exact power can be derived
by the variance explained alone (see later sections).
To scale the above density so that it integrates to 1, we divide the
above density by the normalizing factor
Ð 1
0
le{lVgpwr(Vg)dVg.
Hence the probability density function (pdf) of Vg, corrected for
inadequate coverage of small-effect variants due to limited sample
size, is given by
f (Vg)~
le{lVgpwr(Vg)Ð 1
0
le{lVgpwr(Vg)dVg
Note that the denominator is only a function of l and is not a
function of Vg since Vg is integrated over its possible range.
The above pdf can be used for maximum likelihood estimation
of l from a list of ‘‘significant’’ Vg obtained from genome-wide
association studies. l can be obtained by maximizing the following
log-likelihood function:
lnL(l)~
X
i
ln f (Vgi)
where i refers to the ith observation. The details of deriving the
maximum likelihood estimate (MLE) can be found in the appendix.
Distribution fitting by methods of moments
The theoretical population mean of Vg under the power*-
density curve is given by
mVg~
ð
Vg|f (Vg)dVg
~
ð1
0
Vg|le{lVg|pwr(Vg)dVgð1
0
le{lVg|pwr(Vg)dVg
We can then find the l that gives the closest theoretical mean to
the observed sample mean of Vg from GWAS. In other words, we
solve the following equation,
Ð 1
0
Vg|le{lVg|pwr(Vg)dVgÐ 1
0
le{lVg|pwr(Vg)dVg
~
P
i
Vgi
n
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It turns out that the method of moments and maximum likelihood
give identical estimates for l (the proof is given in Text S1).
Therefore we can use either method for distribution fitting. The
above formulation given by methods of moments is computation-
ally simple.
Relaxing the p-value threshold
Typically in GWAS we only consider the variants that
withstand a Bonferroni correction (typical threshold = 0.05/total
no. of variants) to be significant. However, for fitting the density
curve and estimation of l, a small number of false positives may be
allowed to reduce variance. Here we allow a more liberal
threshold so that more variants can be used in distribution fitting
and estimation of l. At the same time, we make use of the local
false discovery rate (lfdr) procedure [8] to remove the effect of false
positive variants, so that the estimated mean reflect only the effects
of truly associated variants.
The local fdr is the posterior probability of H0 given the test
statistic.
lfdr~Pr (H0DZ~z)
The posterior probability of H1 given the test statistic, or
Pr(H1|Z= z), is given by (1-lfdr). Local fdr is calculated for the
z-value of every SNP (e.g. from Wald test in logistic regression) in a
GWAS. The Vg for each SNP is weighted by 1-lfdr corresponding
to that particular SNP. The weighted mean of Vg can be
expressed by
mVg,weighted~
P
i
wiVgiP
i
wi
where wi~1{Pr (H0DZ~zi)
Although theoretically we may include all SNPs in distribution
fitting, it should be noted that the local fdr around z=0 is often
close to or equal to 1, due to limited sample size. The actual
number of truly associated variants is usually larger than that
predicted by local fdr when z is around 0. Inclusion of all variants
will lead to an underestimation of mean Vg, as the weights for
SNPs with z-values around 0 will be inappropriately low.
Therefore we set an fdr threshold and only considered z-values
corresponding to a fdr lower than a particular value. Here we
assume that when we restrict our consideration to z-values below
the fdr threshold, we can accurately assess the non-null density of z
(denoted f1(z) by Efron), and hence ‘‘recover’’ the Vg correponding
to these non-null z-values. The statistical power (required for the
construction of the power x density curve) is calculated according
to the z-value cutoff. Local fdr was calculated by the locfdr
program by Efron [9].
Figure 1. Probability density of the Vg of detected variants in a GWAS with adjustment for power. We assume an exponential
distribution of Vg for susceptibility variants under unlimited sample size. In practice, sample size and power is limited and small-effect variants will be
under-represented. Therefore the probability density should be adjusted for power. ‘‘Orig density’’ denotes the original exponential distribution, and
the numbers like 2000/2000 denotes the number of cases and controls. The significance threshold was set at 561027 and prevalence set at 0.001.
Lambda equals 2000. The risk allele frequency was assumed at 0.5.
doi:10.1371/journal.pone.0013898.g001
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Fitting the most significant z-values to the alternative
density
Another approach is to consider f1(z), the density of the non-null
z-statistics. Since we assume the Vg of associated variants follow an
exponential distribution with parameter l, we can derive f1(z)
which is also characterized by the parameter l. We may then fit the
most significant z-values to f1(z), and estimate the underlying l.
This is similar to our earlier proposal of fitting observed Vg of
significant markers to the power x density curve, but this time the z-
values instead of Vg are used for distribution fitting.
Evaluating the alternative density of z. Note that the
observed z-values do not equal the true z-values. Denoting the true
z-value by d, then
zDd*N(d,1)
Alternatively, we may consider an observed z-value as a sum of the
true z-value and a random ‘‘noise’’ component which is standard
normal:
z~dzY with Y*N 0,1ð Þ
We first consider the distribution of d. For simplicity, we first
restrict all d to be positive and denote them by d+. Let g be a
function that converts Vg to d, ie
dz~g(Vg)
(since d are all positive, a single Vg can only give a single value of d,
in other words, there is a one-to-one correspondence of Vg and d)
The density of d is given by
f (dz; l)~D 1dg(g{1(dz))=dVgDfVg (g{1(dz); l)
where g{1 is a function converting d+ to Vg and fVg is the density
of Vg. fVg is an exponential distribution characterized by the
parameter l.
Now we consider all values of d, positive and negative. The
distribution of d is symmetrical i.e. f(d) = f(2d), so the above
densities are twice of the overall density which includes all values
of d. The overall density of d is given by
f (d; l)~
1
2
D 1dg(g{1(d))=dVgDfVg (g{1(d); l)
Now we turn to the evaluation of f1 zð Þ.Since we have
z~dzY with Y*N 0,1ð Þ,
we can obtain f1(z) by convolution of the density functions of d and Y:
f1(z)~
ð?
{?
fd(d; l)Q(z{d)dd
Note that f1(z) is determined by parameter l only as we integrate over d.
Fitting observed data to the alternative density. Since the
sample size is limited, we can only detect variants with effect sizes
larger than a certain extent. Assuming a Bonferroni correction is
used and family-wise error rate is set at a, the z-value threshold zcrit
is given by DW{1(a=2N)D where N is the total number of markers in
the study. The observed significant z-values hence follows a
truncated f1(z)with truncation at zcrit and - zcrit. The pdf of the
truncated f1(z) is given by
f1,trunc(z; l)~
f1(z; l)
2
ð?
zcrit
f1(z; l)dz
assuming symmetrical distribution of effect sizes, i.e.
f1(z)= f1({z), such that the truncated area on the left and the
right are equal.
The log likelihood for a set of significant z-values is
l(z; l)~
X
i
log
f1(zi; l)
2
ð?
zcrit
f1(zi; l)dz
0
BBB@
1
CCCA
The MLE of l can be obtained by numerical maximization of the
above likelihood function.
Again one may wish to relax the significance threshold to allow
more variants for distribution fitting. To remove the effects of the
false positive variants, we may employ a weighted likelihood
approach with weights equal to Pr(H1) for each included marker.
Pr(H1) may be estimated by 1 minus the local fdr for each marker.
The weighted likelihood is
l(z; l)~
X
i
wi log
f1(zi; l)
2
ð?
zcrit
f1(zi; l)dz
0
BBB@
1
CCCA where wi
~1{Pr (H0jZ~zi)
For reasons already described above, we set an fdr threshold and
only include SNPs below that threshold.
By fitting the distribution of the truncated f1(z), there is no need
to further correct for winner’s curse because we have already
conditioned on DzDwzcrit. (Since we assume symmetric distribution
of effect sizes, f1(z)= f1({z) and in practice one may work with DzD
instead.)
Correcting for winner’s curse
Winner’s curse refers to the possible overestimation of effect size
of significant genetic variants in association studies. It may be
interpreted as a form of selection bias. The selection of SNPs
meeting significance threshold alters the probability distribution of
odds ratios (or z-values) for the chosen SNPs, resulting in bias in
effect size estimates. The selection bias is most prominent when
the study has weak power and when the significance threshold is
extreme. This is particularly pertinent to genome-wide association
studies, in which the association signals are usually weak and very
stringent significance thresholds are often imposed to guard
against multiple testing. As overestimation of effect size will lead to
overestimation of mean Vg, or underestimation of l, we
investigated various statistical methods based on conditional
likelihood to correct for the winner’s curse.
The details of the winner’s curse correction approaches applied
here were described by Ghosh et al. [10] and Zhong & Prentice
[11]. We consider the test statistic for a single marker in the
Estimating Number of Variants
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following form:
Z~
b^
SE^(b^)
The above statistic is assumed to be asymptotically normal. For
example, when one performs logistic regression to test for SNP
associations, the Wald test statistic will take the above form. b^ then
denotes the estimated regression coefficient.
In our case, we are only interested in SNPs with z-values
exceeding a certain threshold c, where c is chosen such that the
family-wise error rate (FWER) or false discovery rate are controlled
below a certain level. The selection of SNPs passing the significance
cutoff distorts the original normal distribution. The conditional
likelihood after selection can be expressed by [10,12]
Lc(m)~fm(zDDZDwc)~
w(z{m)
W({czm)zW({c{m)
Instead of working with the z-values, Zhong and Prentice [11]
worked with the regression coefficients b and used an equivalent
form of the above conditional likelihood in their paper. Here for
clarity, we focused on the formulation using the z-statistics. A
number of corrected estimates of the effect size have been
proposed based on the above result. Below we briefly describe five
estimators considered in our simulations.
The first one is the MLE estimator
m1,corr~ argmax
m
Lc(m)
which is in fact the same as matching the expectation of the
sampling distribution of m to the observed mean.
The second one is the mean of the normalized conditional
likelihood,
m2,corr~
Ð?
{? mLc(m)dmÐ?
{? Lc(m)dm
which aims to reduce the mean squared error from a Bayesian point of
view. m2,corr may be treated as a posterior mean with a flat prior on m.
The third estimator is the mean of the first two estimators
m3,corr~
m1,corrzm2,corr
2
which aims to combine the strength of the first and second
estimators.
The fourth estimator produces a sampling distribution of z with
median at the observed z-value. The estimator can be expressed as
mmed~m^ :
ðzobs
{?
fm(zDDZDwc)dz~0:5
where zobs is the observed z-statistic for the SNP under study. Note
that Zhong and Prentice [11] dealt with the distribution of
regression coefficient b, but since z and b are directly related
through the fixed SE (z= b/SE), it does not make any difference if
one works with the sampling distribution of z.
The fifth estimator is a weighted average of the uncorrected
regression coefficient estimate (buncorr) and the median corrected
coefficient estimate (bmed ) (note bmed~SE|mmed ). The weight
depends on the estimated variance of the uncorrected coefficient
(s2uncorr) and the difference between the corrected and uncorrected
coefficients.
bMSE,med~K^buncorrz(1{K^)bmed
where K^~
s2uncorr
s2uncorrz(buncorr{bmed )
2
.
All the above correction methods work for binary as well as
continuous outcomes. The first four methods just require z-values
as input. For the last method, an estimate of the standard error of
coefficient is required. As a crude approach, we again assumed a
fixed risk allele frequency of 0.5 so that log(OR) and the standard
error (SE) can be estimated from z-values. It should be noted that
the SE is in fact a function of the risk allele frequency. For the
same level of relative risk and the same z-statistic, a larger SE will
result if risk allele frequency is lower. Ignoring the risk allele
frequency will result in less accurate estimates of SE. Hence it is
recommended that one considers the actual risk allele frequencies
if they are available. In view of this limitation, the results that are
based on the last correction method (i.e the ‘‘MSEmedian’’
estimators) should be regarded as rough estimates only.
Simulation strategy
We simulated z-statistics and investigated the performance of
the various estimators in recovering the underlying parameter that
generates the statistics. The z-statistics were composed of two
groups: the first group corresponded to H0 with distribution N(0,1)
; the second group corresponded to H1 (i.e. truly associated
variants) with distribution N(d,1), where d was determined by the
parameter of the distribution of Vg as described below.
We simulated the Vg of associated variants according to the
exponential distribution,
Vg*exp(l)
Given the allele frequency, prevalence and sample size, one may find
the relative risk that produces the given Vg and hence a corresponding
z-value (denoted d) can be obtained. Since the same Vg gives rise to
similar power and z-values, we simply fix the allele frequency at 0.5.
In each replication we simulated 100,000 z-values, 99.5% of
which are null. The non-null z-values were derived from their
corresponding exponentially distributed Vg. We assumed a
prevalence of 0.001 and a local fdr cut-off of 0.3 throughout. We
investigated the performance of a number estimators under three
different sample sizes (number of cases= 3500, 5000 and 7000 with
equal number of controls) and four different l (1000, 2000, 3000,
4000). The root mean squared error from 300 simulations was
computed. The root mean squared error is given by
RMSE~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPB
i~1
(l{l^i)
2
B
vuuut
where B is the number of simulations, l is the true parameter value
and l^i is the estimated parameter value in the i th simulation.
In total fourteen estimators of l were evaluated. Table 1
provides a summary of the 14 estimators under study. The
estimators fell into two main groups. The first group of estimators
was obtained from fitting only the variants passing a Bonferroni
correction. The family-wise error rate was set at 0.05. The second
group of estimators were obtained from fitting all variants below
Estimating Number of Variants
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an fdr threshold (set at 0.3), which allowed inclusion of an increased
number of markers. In each group, five estimators were obtained by
first applying different winner’s curse correction methods to the
observed effect sizes and then fitting a density x power curve to the
corrected levels of Vg. For comparison, we also included in each
group an estimator derived from fitting the density x power curve but
without any winner’s curse corrections. Lastly, we fit the truncated
convolution density f1(z) to the selected z-values in each group.
Dealing with continuous traits
Although our previous discussions focus on variance explained
of binary outcomes, the method can easily be extended to
continuous traits. The only difference lies in the conversion of Vg
to z and calculation of power given a level of Vg. In fact fewer
assumptions are required for continuous traits. For example, no
extra information on the prevalence of disease is required.
A given level of Vg corresponds to a specific z-statistic and the
same Vg would always give rise to the same power. In summary,
we have the following relations between z and Vg :
z~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(n{2)
Vg
1{Vg
 s
and Vg~
z2
n{2zz2
where n is the sample size.
Recall that we require the derivative dg(Vg)=dVg to construct
the convolution density of z, where g is the function to convert Vg
to z. In the case of a continuous outcome, one can easily obtain a
closed form expression
dg(Vg)
dVg
~
1
2(1{Vg)
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(n{2)(1{Vg)
Vg
s
The mathematical details are given in the supplementary methods
(Text S1).
Confidence interval (CI) for l and number of
susceptibility variants
Non-parametric bootstrap. Non-parametric bootstrap can
be applied to all proposed estimation methods. for construction of
CIs. To perform non-parametric bootstrap, one resamples with
replacement the subjects from the case-control dataset and re-
calculates the test statistic for each SNP in each run. Then repeat the
entire procedure of distribution fitting as described above. The l
found in each bootstrap run is recorded and the confidence interval
of l can be obtained from the empirical distribution of l in
bootstrap runs. The non-parametric bootstrap approach takes into
account of all possible sources of uncertainties, such as uncertainties
in the estimate of the odds ratios and allele frequencies and variation
brought about by winner’s curse correctionmethods. This approach
is relatively straightforward and can be applied to any of the
proposed estimation methods. However, the raw data on the
genotypes and phenotypes of all subjects are required.
Parametric bootstrap. Parametric bootstrap is another way
to obtain the CI when raw data is not available. The basic idea is
to generate many simulated samples (each with the same of
number of observations) from the known distribution of Vg or
z-values, based on the estimated value of l. Then we could re-
estimate l in each simulated sample and obtain a distribution for
l. For example, we considered fitting the pdf of the alternative
z-values, or f1(z; l^). In this case, one simulates z-values based on
the pdf f1(z; l^). Perhaps the easiest way to simulate the z-values is
to first derive the cdf by integrating f1(z; l^) up to various points
and then simulate uniform random variables. Corresponding
random z-values can be generated from the inverse cdf.
As the bootstrap methods are more computationally intensive
than analytic methods, we will focus on the latter in simulations
and applications to a few real datasets. Bootstrap methods
however may have better performance particularly when the
number of observations is small. If access to the raw data is
available, non-parametric bootstrap is also applicable and has the
merit of being free from distributional assumptions.
Table 1. An overview of the proposed estimators of l.
Name of estimator
SNP inclusion
criteria
Distribution fitting
method
Winner’s curse
correction
Corresponding
number-
ing in figures
Bonf Bonf pwr*exp_density None 1
Bonf.corr Bonf pwr*exp_density Avg of Ghosh 1&2 2
Bonf.corr1 Bonf pwr*exp_density Ghosh 1 3
Bonf.corr2 Bonf pwr*exp_density Ghosh 2 4
Bonf.corr.med Bonf pwr*exp_density Median (Zhong) 5
Bonf.corr.MSEmedian Bonf pwr*exp_density MSE median (Zhong) 6
Bonf.fitfZ.conv Bonf f1conv Not necessary 7
truncfdr fdrthres pwr*exp_density None 1
truncfdr.corr fdrthres pwr*exp_density Avg of Ghosh 1&2 2
truncfdr.corr1 fdrthres pwr*exp_density Ghosh1 3
truncfdr.corr2 fdrthres pwr*exp_density Ghosh2 4
truncfdr.corr.median fdrthres pwr*exp_density Median (Zhong) 5
truncfdr.corr.MSEmedian fdrthres pwr*exp_density MSE median (Zhong) 6
truncfdr.fitfZ.conv fdrthres f1conv Not necessary 7
Bonf, Bonferroni correction; fdrthres, local fdr threshold; pwr*exp_density, fitting by the power times exponential density curve; flconv, fitting by considering the
convolution density of non-null observations f1(z); Avg, average. The winner’s curse correction methods are named by the first author of the corresponding reference
papers. Please see the text for details.
doi:10.1371/journal.pone.0013898.t001
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Analytic approaches. A common analytic approach for
calculating CI is to assume normality of the parameter and obtain
the SE by inversion of the Fisher information matrix.
Alternatively, one may obtain CI by inverting hypothesis tests,
such as the maximum likelihood ratio test (MLRT).
These analytic methods for calculation of CI however cannot
directly be applied when we estimate l by fitting to the distribution
of observed Vg with correction for winner’s curse. Note that we
assume the actual Vg is exponentially distributed and hence fit the
power x exponential density curve to the data. What we obtain
from association studies however is not the actual Vg but Vg with
random sampling variation. Put it another way, the Vg is derived
from the allele frequencies and odds ratios. Both of them have
sampling variations (especially the odds ratios) and would not be
identical when we repeat the study. Nevertheless our approach is
to fit the estimated ‘‘true’’ Vg to the exponential density multiplied
by power. The uncertainties of the allele frequencies and ORs
have not been dealt with in the model.
Hypothetically, if one is able to fit the observed data to the
actual sampling distribution of Vg, then the analytic approaches for
obtaining CI are applicable. But since the form of this distribution
is difficult to obtain, we cannot obtain CIs by analytic means
directly. Correction for winner’s curse introduces further varia-
tions. The effect to the variance and CI of the final l estimate is
not straightforward. In addition, different ways of winner’s curse
correction have different effects on the variances of l, as shown in
our simulations.
Analytic means of calculating CI can be applied when we fit the
significant variants to the convolution density f1(z) directly. Note
that the sampling variation of effect size has been incorporated
since the convolution already takes into account the random
Gaussian noise added to the actual z-value.
Two standard analytic methods in deriving the confidence
interval were used. The first one is based on inverting the observed
Fisher information evaluated at the MLE. It may be expressed as
the negative of the 2nd derivative of the log-likelihood function,
Il^(x)~{l’’l^(x)~{
d2ll(x)
dl2 Dl~l^
where x represent the observed data, l is the parameter to
estimate and l^ is the MLE. The confidence interval of l is given by
l^+Il^
{1=2za=2
assuming normality of the parameter estimate.
The second approach is derived from the maximum likelihood
ratio test (MLRT). It is based on the duality of hypothesis testing
and interval estimation. To construct a confidence interval with
coverage 12a, we consider the acceptance region of a test of size a
for H0 : l~l0VsH1 : l=l0. Here we just consider a single
parameter for simplicity. The maximum likelihood ratio test has
the following test statistic which follows a chi-square distribution:
2½l(l^; x){l(l0; x)*x21
We are interested in all the lambdas such that the null hypothesis is
not rejected, or more simply, the lambdas that are not significantly
different from the MLE. The confidence interval with coverage
12a includes all l0 satisfying
2½l(l^; x){l(l0; x)ƒx21,1{a
or l(l0; x)§l(l^; x){
x21,1{a
2
Simulation on coverage probabilities of CIs
It is less clear whether these analytic approaches would work if
we worked with weighted maximum likelihood. To assess the
coverage probability of the proposed analytic CIs, we performed a
brief simulation study on a sample size of 3500 cases and 3500
controls and lambdas of 1000, 2000 and 3000. One thousand
simulations were carried out. In each simulation run, random
z-values are generated as previously described. Ninety-five percent
confidence intervals of the parameter l were computed using two
analytic methods (inversion of Fisher information matrix and
MLRT), for markers passing Bonferroni correction and for those
passing the local fdr threshold of 0.3. We evaluated coverage
probabilities and the width of the CIs.
Application to real data
The above distribution fitting methods were applied to a few
real disease examples. As estimation of the local fdr requires all
summary statistics to be available, we focused on studies that had
full summary statistics released before. We included three large-
scale studies, one on lipid levels [13], one on type 2 diabetes [14]
and the other on Crohn’s disease [15]. As the SNPs in a GWAS
are correlated due to linkage disequilibrium (LD), several markers
may be in strong LD with one casual variant and still show
statistical significance. The mean effect size or Vg may be inflated
as the signals from these proxy markers were counted as well. We
experimented a rough pruning procedure to reduce the effect of
correlation. The pruning was applied to the diabetes and Crohn’s
datasets and SNPs were pruned such that they were at least 30 kb
apart.
For the Crohn’s disease dataset [15], we also tried to estimate
the effect sizes from the replication study alone to replace winner’s
curse corrections. The loci listed in Table 2 of [15] were taken to
be the true associated variants. The power was calculated based on
the probability of passing both the 1st-stage p-value threshold
(,561025) and the 2nd-stage threshold (,0.0008 or 0.05/63 by
Bonferroni correction) given the effect size. l was estimated by the
same distribution fitting procedure as detailed previously.
Fitting other types of distributions to real data
Although we have focused on the exponential distribution in
this study, we noted that this is only theoretical and may not exactly
be the true model in real scenarios (please see the discussion
section for further details). Particularly, the effect size distribution
of complex traits may be more skewed towards zero than an
exponential distribution, as suggested in Park et al. [6]. Therefore
we have also tried to fit other types of distributions to the real data
and observe how the parameter estimates will change. We have
chosen to fit gamma distributions as an alternative to exponential
distribution. This is because the gamma distribution is highly
flexible with both shape and scale parameters. When the shape
parameter is one, it is equivalent to an exponential distribution.
Distributions that are more skewed towards zero than an
exponential density have shape parameters less than one. We set
different shape parameters and the scale parameter estimates were
estimated by fitting the alternative density of z-values (the
methodology is described under the section ‘‘Fitting the most
significant z-values to the alternative density’’). The mean of a
gamma distribution is simply the product of the shape and scale
parameters.
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Results
Simulation results for estimators of l
Tables 2, 3 and 4 shows the overall performance of 14 different
estimators as measured by the root mean squared error from 300
simulations. In total 12 scenarios were studied. Firstly, we focus on
the comparison of using only the most significant variants passing
Bonferroni correction versus using all variants below a certain
local fdr threshold. It is clear that by relaxing the p-value threshold
and then removing the false positive effects by local fdr weighting,
the root mean squared error can be reduced. The mean, bias and
SD of different estimators were shown in tables S2 and S3. The
variance (or SD) of the estimators decreased when we allowed
more markers for fitting with adjustments for false positives using
fdr. The improvement was more marked when the effect size was
small (i.e. true l is large) and the sample size was not large. For
example when Ncase =Nctrl = 3500 and l is 4000, the SD of the fdr-
adjusted estimators was only about one-third of the SD of the
Bonferroni- adjusted counterparts. The bias of the fdr-adjusted
estimators were also in general smaller than that of the Bonferroni-
adjusted ones, but for the last two (‘‘MSEmedian’’ and
‘‘fitfZ.conv’’[i.e. fitting f1(z)]) this situation was often reversed.
Figures 2 and 3 show the boxplots of the different estimators.
For the estimators in figure 2, variants were included in fitting if
they passed the Bonferroni threshold. The last two estimators
(‘‘MSEmedian’’ and ‘‘fitfZ.conv’’) were nearly unbiased and had
Table 2. Root mean squared error of different estimators from simulations when number of cases and controls each equals 3500.
RMSE l=1000 l=2000 l=3000 l=4000
N=3500 RMSE rank RMSE rank RMSE rank RMSE rank
Bonf 198 12 783 13 1553 14 2403 11
Bonf.corr 201 13 773 12 1520 13 2841 12
Bonf.corr1 159 11 645 11 1408 11 3065 13
Bonf.corr2 237 14 845 14 1477 12 2318 10
Bonf.corr.med 123 8 443 8 1001 8 2311 9
Bonf.corr.MSEmedian 93 6 323 4 802 7 1866 7
Bonf.fitfZ.conv 91 4 352 6 1021 9 3795 14
truncfdr 140 10 625 10 1335 10 2151 8
truncfdr.corr 110 7 407 7 692 5 1035 5
truncfdr.corr1 92 5 339 5 615 4 998 4
truncfdr.corr2 126 9 446 9 694 6 936 2
truncfdr.corr.median 71 1 221 1 418 1 730 1
truncfdr.corr.MSEmedian 77 3 282 3 593 3 970 3
truncfdr.fitfZ.conv 74 2 245 2 520 2 1236 6
doi:10.1371/journal.pone.0013898.t002
Table 3. Root mean squared error of different estimators from simulations when number of cases and controls each equals 5000.
RMSE l=1000 l=2000 l=3000 l=4000
N=5000 RMSE rank RMSE rank RMSE rank RMSE rank
Bonf 131 12 570 13 1212 12 1991 14
Bonf.corr 139 13 567 12 1233 13 1874 12
Bonf.corr1 114 11 451 11 1045 11 1670 10
Bonf.corr2 161 14 656 14 1326 14 1894 13
Bonf.corr.med 103 10 348 9 746 9 1184 9
Bonf.corr.MSEmedian 84 6 243 5 532 4 959 7
Bonf.fitfZ.conv 82 5 245 6 574 6 1155 8
truncfdr 88 7 431 10 978 10 1679 11
truncfdr.corr 91 8 294 7 671 7 916 5
truncfdr.corr1 81 4 242 4 569 5 794 4
truncfdr.corr2 100 9 335 8 724 8 943 6
truncfdr.corr.median 69 2 182 1 371 1 491 1
truncfdr.corr.MSEmedian 65 1 217 3 437 3 721 3
truncfdr.fitfZ.conv 72 3 182 2 407 2 620 2
doi:10.1371/journal.pone.0013898.t003
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comparable variance. Figure 3 shows estimators that were fdr-
adjusted. Overall speaking, the median and fitfZ.conv estimators
had the lowest bias among all. The estimator without winner’s
curse correction was clearly downward biased, no matter which
kind of inclusion threshold was used.
Considering the overall performance of all estimators, three
estimators stood out as the best three in 10 out of 12 scenarios.
They included ‘‘truncfdr.corr.median’’, ‘‘truncfdr.corr.MSEme-
dian’’ and ‘‘truncfdr.fitfZ.conv’’ (please refer to table 1 for a
description of the estimators). As expected, all three were
estimators using fdr adjustment. Among winner’s curse correction
approaches, the median and MSE median estimators outper-
formed others in the current study. Fitting directly by f1(z) also
had favorable performance.
Simulation results for confidence intervals of l
Table 5 shows the properties of CIs obtained from 1000
simulations, including coverage probabilities, mean and SD of the
width of CI, and the value of the upper and lower 95% CI averaged
from the simulations. Under the three simulated scenarios, all four
CIs had coverage probabilities close to the theoretical value (0.95),
although for ‘‘MLRTweighted’’ (maximum likelihood ratio test using
weighted likelihood) the coverage probability seemed to be slightly
lower than 0.95. By employing the weighted likelihood approach, we
were able to include more variants and not surprisingly, the width of
CI was much shorter than that from a standard likelihood approach.
The SD of the CI width was also smaller.
Results for real disease data
For Crohn’s disease, we have tried an approach that did not
require any winner’s curse corrections. The effect sizes of the true
associated variants were extracted from replication studies as
described in [15]. l was estimated at 1196 and hence the estimate
of mean Vg was 0.0836%. The other results were summarized in
table 6. Only the results based on fdr adjustment were shown since
they are superior to Bonferroni-corrected estimators. Readers may
refer to table S4 for the Bonferroni-corrected results for reference.
The estimated values of l range from about a few hundreds to
around two thousand. Pruning of SNPs did not change the
estimates substantially, though we noted an increase in l for the
Crohn’s dataset after pruning. The estimated number of
susceptibility variants is simply given by the heritability multiplied
by l. The heritabilities for type 2 DM and Crohn’s disease were
taken to be 0.424 [16] and 0.55 [17]. The heritabilities of HDL,
LDL and TG were taken to be 0.63, 0.36 and 0.37 respectively
according to Abney et al. [18]. As shown in table 6, the estimated
number of susceptibility variants underlying the studied traits
ranged from around four hundred to a thousand. Table 7 showed
the estimated number of variants when we assumed a gamma
distribution that allows a greater number of SNPs with smaller
effects. A smaller shape parameter implies that the distribution is
more skewed towards zero. As one would expect, the estimated
number of variants went up as the distribution is increasingly
skewed towards zero. The resulting estimates were about two to
three times of the original estimate (based on exponential
assumption) when the shape parameter decreased to 0.3.
Discussion
In this study we proposed a variety of methods to estimate the
number of susceptibility variants in the genome based on the
assumption that effect sizes are exponentially distributed.
One advantage of our methodology is that all proposed
estimators require only the summary statistics (z-values or p-values)
rather than the raw data, although the availability of raw data allows
non-parametric bootstrap to evaluate confidence intervals. If only
the z or p-values of the most significant markers are available, the
models can still be fit, but one should be aware that distribution
fitting on a small number of markers is often unstable.
Another feature of our methodology is that we used the variance
explained as a measure of effect size. It is worth noting that the
variance explained depends on both the allele frequency and the
relative risk (RR). A rare variant with a large effect size may have
similar Vg as a common variant with smaller effect size. For
example, under a prevalence of 0.01, a variant with risk allele
frequency (RAF) 0.5 and allelic RR 1.1 has the same Vg
(0.0639%) as another variant with RAF 0.0005 and RR 6.348 with
Vg (assuming allelic RR is multiplicative). The exponential
Table 4. Root mean squared error of different estimators from simulations when number of cases and controls each equals 7000.
RMSE l=1000 l=2000 l=3000 l=4000
N=7000 RMSE rank RMSE rank RMSE rank RMSE rank
Bonf 87 11 395 12 905 12 1552 12
Bonf.corr 91 13 403 13 915 13 1587 13
Bonf.corr1 78 8 319 11 733 11 1338 11
Bonf.corr2 104 14 474 14 1045 14 1715 14
Bonf.corr.med 72 5 258 9 548 8 1011 9
Bonf.corr.MSEmed 64 3 190 6 381 5 716 6
Bonf.fitfZ.conv 65 4 180 4 357 4 678 4
truncfdr 60 1 291 10 684 10 1247 10
truncfdr.corr 84 10 222 7 487 7 817 7
truncfdr.corr1 78 9 190 5 397 6 680 5
truncfdr.corr2 89 12 252 8 555 9 897 8
truncfdr.corr.median 72 6 162 3 304 3 486 3
truncfdr.corr.MSEmedian 64 2 156 1 283 2 471 2
truncfdr.fitfZ.conv 73 7 158 2 282 1 470 1
doi:10.1371/journal.pone.0013898.t004
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distribution of Vg is compatible with numerous rare variants with
large RR or numerous common variants with small RR, or a
combination of both. Since current GWAS panels only focus on
common variants, we are estimating the parameter of the
exponential distribution based on the set of common SNPs, and
hoping the result can be extrapolated to rare variants.
We have also applied the methodology to a number of real
disease traits. The results suggested that roughly hundreds of
susceptibility variants underlie these traits. This is not particularly
striking, as many researchers might have expected that a large
number of variants are implicated from the polygenic model for
complex diseases. However, we have shown how to quantify the
number of susceptibility variants, albeit approximately, in a
statistical framework. We also noted that GWAS have been
relatively successful for the traits studied here: over 20 loci have
been identified for type 2 diabetes and around 30 loci have been
identified for Crohn’s disease [15] and lipid levels [13]. The
genetic architecture of these few traits need not represent that of
other complex diseases. Many diseases or traits have not been
examined in large-scale or meta-analytic GWAS yet, it would be
interesting to perform the analyses on these datatsets and compare
the estimated number of variants for different outcomes.
Limitations
To accurately infer the number of total susceptibility variants in
the genome from GWAS data is a very difficult problem, and the
methodology presented here should only be interpreted as a rough
estimate based on the exponential distribution assumption. We
stress that the work presented here is not a perfect solution to the
problem. Instead, we made our best attempt to estimate the
Figure 2. Boxplots of different estimators of l, with inclusion threshold based on Bonferroni correction.
doi:10.1371/journal.pone.0013898.g002
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number of variants, and more importantly, we hoped to provide a
useful and rigorous statistical framework to attack the problem.
One difficulty in dealing with GWAS data is that the SNPs are
correlated, while most distribution fitting methods in statistics
apply to independent observations. Often clusters of SNPs may
show high significance but may just contain one or few true
independent signals. As a result of the ‘‘redundant’’ significant
signals, the mean Vg may be overestimated and l underestimated.
In addition the strong correlation may distort the assumed
exponential distribution of effect sizes. One way to alleviate this
problem is to prune the SNPs before analyses so that they are
roughly independent. On the other hand, pruning reduces the
number of markers available for distribution fitting and will
increase the variability of the estimates, especially when the effect
sizes are small and there are few markers considered significant
even in the entire set of genotyped SNPs. There is no perfect
solution to this sort of bias-variance tradeoff. However, as the
sample size becomes larger, more SNPs will pass the significance
threshold and there will be adequate SNPs for stable parameter
estimates even if the SNPs are pruned prior to analysis.
Also, the significant associations in a GWAS may not be causal
variants themselves, but maybe merely tagging them. We have to
assume that the variance explained by significant results in a
GWAS is close to that of the causal variants if they were typed.
Current GWAS technologies mainly aim at capturing common
variants. As a result, the best thing we can do is to infer the total
number of underlying based on the effect sizes of common
variations. The contribution of rare variants and structural
Figure 3. Boxplots of different estimators of l, with inclusion threshold based on local fdr.
doi:10.1371/journal.pone.0013898.g003
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variations to complex diseases is largely unexplored in the
literature. In addition, gene-gene or gene-environmental interac-
tions may also play a role in the etiology of complex diseases, but
our current understanding regarding interactions is still very
limited. To make predictions on the total number of susceptibility
variants in the genome, inevitably we have made the assumption
that the other variants that are not captured share a similar
distribution of Vg as common variants. Of course this assumption
may not work very well in practice. Nonetheless, we think this
limitation may become less of a concern in the future when studies
accumulate and technologies improve. While now we can only fit
the Vg of common variants, with more rare and structural variants
discovered in the future, their effect sizes may also be fit using the
proposed framework. Interactions may be regarded as multi-locus
genotypes and their Vg can be readily calculated and distribution
fitting can be done as well. The framework we presented does not
pose any restrictions on the actual nature of the susceptibility
variants. With accumulation of more studies we will hopefully be
able to obtain more reliable estimates considering a greater variety
of genetic variations.
We assumed an exponential distribution of Vg in this study,
which is justified by theories in adaptation [3]. The exponential
distribution is simple with only one parameter, hence the
estimation can be quite reliable despite modest sample size.
Employing more flexible models with more parameters would
allow better fitting when the true distribution is not exponential.
However, we will need much larger sample sizes such that there
are enough variants passing the significance threshold (Bonferroni
or fdr) that are available for fitting. Otherwise, the estimate will be
unstable.
Despite the advantages, we must point out that the exponential
assumption is a theoretical prediction after all, and may not be
exactly true in practice. For example, Park et al.[6] suggested
recently that the effect size distributions for complex traits may be
Table 5. Simulation results for different estimates of 95%
confidence intervals (CI).
True lambda
1000 2000 3000
Coverage probability Info 0.949 0.959 0.953
Info weighted 0.936 0.955 0.969
MLRT 0.953 0.954 0.946
MLRT weighted 0.93 0.942 0.948
Average width of CI Info 359 1348 3703
Info weighted 285 877 2025
MLRT 360 1370 4007
MLRT weighted 285 883 2069
SD of width of CI Info 39 296 2213
Info weighted 24 122 454
MLRT 39 307 2452
MLRT weighted 25 124 477
Mean value lowCI (info) 831 1402 1423
upCI (info) 1190 2750 5127
lowCI (info weighted) 882 1623 2175
upCI (info weighted) 1166 2500 4201
lowCI (MLRT) 843 1492 1865
upCI (MLRT) 1203 2862 5872
lowCI (MLRT weighted) 889 1663 2318
upCI (MLRT weighted) 1174 2545 4387
‘‘Info’’ refers to CI obtained by inversion of Fisher information matrix.
‘‘Weighted’’ refers to weighting by the 1-local fdr.
MLRT, maximum likelihood ratio test; lowCI, lower 95% CI; upCI, upper 95% CI.
doi:10.1371/journal.pone.0013898.t005
Table 6. Estimates and confidence intervals of lambda for a few complex traits, variants included according to fdr threshold.
HDL LDL TG DM(all SNPs) DM(pruned) Crohn(all SNPs) Crohn(pruned)
Estimates of lambda
truncfdr 634 828 989 692 652 1086 1249
truncfdr.corr 827 1203 1534 1380 1215 1615 2062
truncfdr.corr1 813 1190 1522 1344 1150 1569 1976
truncfdr.corr2 835 1198 1519 1374 1256 1642 2117
truncfdr.corr.median 769 1115 1403 1244 1042 1442 1787
truncfdr.corr.MSEmedian NA NA NA 1116 926 1329 1603
truncfdr.fitfZ.conv 693 975 1192 1162 1192 1388 1715
Confidence intervals
upCI.wt (fdrthres) 751 1056 1257 1363 2420 1553 2348
loCI.wt(fdrthres) 635 895 1128 960 236 1222 1083
upCI.MLRT.wt(fdrthres) 881 1152 1460 1380 3344 1562 2438
loCI.MLRT.wt(fdrthres) 561 835 996 975 397 1229 1183
Esimated no. of susceptibility variants
based on truncfdr.corr.median 484 401 519 527 442 793 983
based on truncfdr.fitfZ.conv 437 351 441 493 505 763 943
The bolded lines refer to estimators having the best overall performance in simulations.
HDL, high density lipoprotein; LDL, low density lipoprotein; TG, triglyceride; DM, type 2 diabetes mellitus; Crohn, Crohn’s disease.
Bonf, inclusion threshold based on Bonferroni correction; fdrthres, inclusion threshold set at local fdr of 0.3.
‘‘wt’’ refers to weighting by 1-local fdr. Please refer to the previous tables for abbreviations of the estimators and the types of CI calculated.
doi:10.1371/journal.pone.0013898.t006
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more skewed to the left than an exponential distribution. As a
result, we may have underestimated the total number of
susceptibility loci. In view of this limitation, we have also tried
to fit gamma distributions with shape parameters less than one,
which allow more variants with small effect sizes than an
exponential distribution. When the shape parameter dropped to
0.3, the estimated number of loci increased by about 2 to 3 times
compared to the case when the exponential distribution is fitted.
The new estimates are mostly in the range of one to two
thousands. This gives a rough idea of the range of estimates if the
distribution of effect size is more left-skewed.
As first mentioned in the introduction, Park et al. [6] recently
have worked on a similar problem. It is notable that Park et al.
have proposed a way to deal with the problem in a non-parametric
manner without relying on estimate of total heritability. However,
it should be noted that we are considering the entire range of effect
sizes rather than the observed range, which is a bit trickier. The
unobserved effect sizes are likely to be smaller than the observed
ones and cannot be modeled easily. Note that non-parametric
methods are usually highly flexible. They can fit the observed data-
points well (and may perform well within the range of effect sizes
observed). However, flexible models also increase the risk of
overfitting. They may be less reliable at predicting future data-
points as they may magnify the ‘‘noise’’ or random fluctuations in
the original data. The danger of overfitting is exaggerated when
we have to extrapolate beyond the observed spectrum of effect sizes.
The risk of overfitting is also heightened when the number of loci
(i.e. data-points) available for fitting is small in the first place, as
explained earlier.
As a result, we have focused on the more restrictive parametric
models in the current study, and in particular the exponential
model. This is not because the exponential model is perfect, but it
is the only parametric model with theoretical support and
represents the best ‘‘educated guess’’ of effect size distribution in
our view. One may change the exponential assumption to other
models such as gamma distributions, as was done in this study.
With greater sample sizes for association studies and more loci
available for fitting, one may be able to reliably fit statistical
distributions with more free parameters, for example the gamma
distribution (which is very flexible) with free shape and rate
parameters. The reliance on the exponential distribution can then
be relaxed. The framework presented in this paper can potentially
be extended to deal with other types of distributions.
It should be noted that our methodology requires an external
estimate of the total heritability. As there are many different
statistical approaches and designs that are available for heritability
studies, one may need to be aware of the limitations of different
heritability estimates. For example, twin and adoption studies can
separate shared environmental from shared genetic factors in
families, while family-based studies (e.g. those based on siblings
and parent-offsprings only) cannot make a distinction between the
two types of shared effects.
We have proposed an fdr-based approach to relax the
significance threshold so that more markers are available for
fitting. Simulations showed that this approach had superior
performance when compared to the conventional way of including
only the markers that passed the Bonferroni threshold. In practice,
confounding factors such as population stratification may be
present to increase the false positive rate. Many methods such as
principal component analysis are available for correcting popula-
tion stratification [19]. If major residual confounding is suspected,
for example the genomic inflation factor (l) [20] remains high after
correction by principal component analysis, then one should be
cautious in relaxing the significance threshold. In such cases, one
should also be alert to the most significant markers being false
positives, and extensive replications are necessary to confirm the
results. One may also consider correcting the results by genomic
control [20].
Goldstein [21] presented an alternative approach to estimate
the number of variants underlying height in a recent commentary.
His approach is different from ours and Park et al. [6]. In [6] and
our study, the authors considered the probability density function
of effect sizes and obtained parameters estimates by distribution
fitting. Goldstein considered the entire range of effect sizes as we
do. However, he ranked the SNP from largest to smallest effect
sizes and plotted the effect size (in variance explained) (on y-axis)
against the rank of each SNP (on x-axis). An exponential function
curve was fit to the observed data-points with least-squares
regression. Essentially the rank of SNP is the predictor variable
and the effect size is the outcome variable. The number of variants
is solved using integration. This is not the same as the probably
more intuitive and conventional distribution fitting methods in
Table 7. Estimated number of susceptibility variants
assuming a gamma distribution of effect sizes.
Shape Lambda Mean
Number of
variants
LDL 0.9 937 9.60E-04 375
0.7 845 8.28E-04 435
0.5 754 6.63E-04 543
0.3 664 4.52E-04 797
HDL 0.9 657 1.37E-03 460
0.7 585 1.20E-03 526
0.5 514 9.73E-04 648
0.3 445 6.74E-04 935
TG 0.9 1152 7.81E-04 474
0.7 1038 6.75E-04 548
0.5 812 6.16E-04 601
0.3 924 3.25E-04 1140
Crohn (all) 0.9 1328 6.78E-04 812
0.7 1211 5.78E-04 951
0.5 1093 4.57E-04 1203
0.3 970 3.09E-04 1779
Crohn (pruned) 0.9 1649 5.46E-04 1008
0.7 1512 4.63E-04 1188
0.5 1375 3.64E-04 1513
0.3 1219 2.46E-04 2235
DM (all) 0.9 1122 8.02E-04 528
0.7 1042 6.72E-04 631
0.5 962 5.20E-04 816
0.3 884 3.40E-04 1249
DM (pruned) 0.9 1165 7.73E-04 549
0.7 1095 6.39E-04 663
0.5 1026 4.87E-04 870
0.3 994 3.02E-04 1405
When the shape parameter equals one, the gamma distribution is equivalent to
an exponential distribution and the results are listed in table 6. When the shape
parameter decreases, the distribution is more skewed towards zero, implying
that we assume more variants to have small effect sizes.
doi:10.1371/journal.pone.0013898.t007
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which one fits a distribution to the histogram of effect sizes (i.e. y-
axis is the density, x-axis is the effect size). Goldstein’s method was
only described briefly and the statistical methodology itself was not
the major focus of the commentary. No detailed rationale for the
approach or simulations was presented. Hence we are unable to
make rigorous and comprehensive comparisons of our approach to
that described in Goldstein. However, it is clear that in Goldstein’s
approach, the power of study is not considered and as admitted by
the author, it is assumed that all SNPs yet to be found have smaller
effects than the weakest one discovered to date. This will lead to an
overestimation of the number of variants.
Estimation of the number of variants underlying a trait is a very
challenging task. We believe that for most complex diseases, the
Vg of susceptibility variants are likely to be rather small. It may be
possible to investigate the aggregate effect of these variants, for
example Purcell et al. [22] showed a large number of SNPs (with p
values up to 0.5) from a schizophrenia GWAS demonstrate
predictive power collectively. It will be much harder to estimate
the number of variants making up this combined effect as the Vg of
each variant is probably tiny. For instance, it may be difficult to
distinguish between 100 variants having an average Vg of 0.01%
versus 10 variants having an average Vg of 0.1%.
In conclusion, we have developed a novel statistical approach to
estimate the number of susceptibility variants in the genome. The
performance of different proposed estimators were tested by
simulations and applied to some real data examples. Despite the
limitations, we believe this study is a useful step towards the
understanding of the genetic architecture of complex diseases.
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